Submitted by Anonymous (not verified) on 23 June 2026 - 8:35
Opinion/decision on a Paediatric investigation plan (PIP): Otezla, apremilast, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0352/2022
Source: